SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001493152-21-022097
Filing Date
2021-09-07
Accepted
2021-09-07 16:05:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 formsc13d.htm SC 13D 92102
2 ex99-1.htm EX-99.1 6483
  Complete submission text file 0001493152-21-022097.txt   100156
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Subject) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: SC 13D | Act: 34 | File No.: 005-92289 | Film No.: 211239342
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 FIRST CANADIAN PLACE 39TH FLOOR TORONTO A6 M5X 1H3
Business Address 1 FIRST CANADIAN PLACE 39TH FLOOR TORONTO A6 M5X 1H3 5142437438
L5 Capital Inc. (Filed by) CIK: 0001869759 (see all company filings)

IRS No.: 000000000
Type: SC 13D